> Merkliste Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp: E-Artikel Titel: Elucidating the roles of ASPM isoforms reveals a novel prognostic marker for pancreatic cancer Beteiligte: Timaner, Michael; Shaked, Yuval Erschienen: Wiley, 2020 Erschienen in: The Journal of Pathology Sprache: Englisch DOI: 10.1002/path.5355 ISSN: 0022-3417; 1096-9896 Schlagwörter: Pathology and Forensic Medicine Entstehung: Anmerkungen: Beschreibung: <jats:title>Abstract</jats:title><jats:p>Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide. Late diagnosis, desmoplastic tissue and intrinsic resistance to therapy are among the main reasons for its aggressive phenotype. In addition, it is now appreciated that cancer stem cells – a rare subpopulation of tumor cells highly resistant to therapy – are crucial players in PDAC initiation, progression and resistance to therapy. In a recent article in <jats:italic>The Journal of Pathology</jats:italic>, Hsu <jats:italic>et al</jats:italic> elucidated the specific roles of abnormal spindle‐like, microcephaly‐associated protein (ASPM) isoforms in PDAC. The authors reported that ASPM isoform I (ASPM‐iI) is mainly expressed in the cytoplasm of PDAC cells. Its expression is associated with the Wnt signaling pathway, which promotes stemness and maintains the cancer stem cell niche. Clinically, expression of ASPM‐iI correlates with poor survival in PDAC patients. Thus, this study revealed a novel prognostic marker as well as a potential therapeutic target for PDAC. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.</jats:p>